Maternal Use of Antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children

JAMA. 2017 Nov 7;318(17):1700-1701. doi: 10.1001/jama.2017.14485.

Abstract

Clinical question: Is maternal use of antiepileptic drugs during pregnancy associated with major congenital malformations in children?

Bottom line: Certain antiepileptic drugs were associated with increased rates of congenital malformations (eg, spina bifida, cardiac anomalies). Lamotrigine (2.31% in 4195 pregnancies) and levetiracetam (1.77% in 817 pregnancies) were associated with the lowest risk and valproate was associated with the highest risk (10.93% in 2565 pregnancies) compared with the offspring of women without epilepsy (2.51% in 2154 pregnancies).

MeSH terms

  • Abnormalities, Drug-Induced*
  • Anticonvulsants / adverse effects*
  • Epilepsy / drug therapy*
  • Female
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Pregnancy Complications / drug therapy*
  • Review Literature as Topic

Substances

  • Anticonvulsants